North America Ai In Genomics Market Size & Outlook
North America ai in genomics market, 2018-2030 (US$M)
Related Markets
North America ai in genomics market highlights
- The North America ai in genomics market generated a revenue of USD 205.9 million in 2023.
- The market is expected to grow at a CAGR of 45.2% from 2024 to 2030.
- In terms of segment, drug discovery & development was the largest revenue generating application in 2023.
- Precision Medicine is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 205.9 million |
| Market revenue in 2030 | USD 2,802.2 million |
| Growth rate | 45.2% (CAGR from 2023 to 2030) |
| Largest segment | Drug discovery & development |
| Fastest growing segment | Precision Medicine |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Discovery & Development, Precision Medicine, Diagnotics |
| Key market players worldwide | International Business Machines Corp, Microsoft Corp, NVIDIA Corp, Freenome, Thermo Fisher Scientific Inc, Illumina Inc, Sophia Genetics SA, Benevolent AI, Deep Genomics, Data4Cure, Fabric Genomics (formerly Omicia) |
Other key industry trends
- In terms of revenue, North America region accounted for 29.1% of the global ai in genomics market in 2023.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,672.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
AI In Genomics Market Scope
AI In Genomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America ai in genomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai in genomics market will help companies and investors design strategic landscapes.
Drug discovery & development was the largest segment with a revenue share of 33.27% in 2023. Horizon Databook has segmented the North America ai in genomics market based on drug discovery & development, precision medicine, diagnotics covering the revenue growth of each sub-segment from 2018 to 2030.
- North America AI In Genomics Application Outlook (Revenue, USD Million, 2018-2030)
- Consumer Electronics
- Healthcare
- Automotive
- Military & Defense
- Media & Entertainment
- Drug Discovery & Development
- Precision Medicine
- Diagnotics
- Others
- Drug Optimization & Repurposing
- Preclinical Testing
- Orthopedics
- Neurology
- Urology
- Gynecology
- North America AI In Genomics Component Outlook (Revenue, USD Million, 2018-2030)
- Processor
- Connectivity IC
- Sensors
- Software
- Hardware
- Services
- North America AI In Genomics Technology Outlook (Revenue, USD Million, 2018-2030)
- Machine Learning
- Computer Vision
- North America AI In Genomics Functionality Type Outlook (Revenue, USD Million, 2018-2030)
- Genome Sequencing
- Gene Editing
- Others
- North America AI In Genomics End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical & Biotechnology
- Healthcare Providers
- Research Centers
- Others
Reasons to subscribe to North America ai in genomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America ai in genomics market databook
-
Our clientele includes a mix of ai in genomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America ai in genomics market , including forecasts for subscribers. This continent databook contains high-level insights into North America ai in genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America ai in genomics market size, by country, 2018-2030 (US$M)
North America AI In Genomics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
